Zobrazeno 1 - 10
of 98
pro vyhledávání: '"D. L. Citrin"'
Publikováno v:
American Journal of Clinical Oncology: Cancer Clinical Trials. 23:589-592
Twenty-nine patients with progressive hormone-refractory metastatic adenocarcinoma of the prostate were treated with daily estramustine phosphate at 10 mg/kg, and I.V. doxorubicin 50 mg/m 2 every 3 weeks. Twenty-six patients were evaluable. Four of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30915f027c516918d414726865be2e95
https://doi.org/10.1097/00000421-200012000-00012
https://doi.org/10.1097/00000421-200012000-00012
Publikováno v:
American journal of clinical oncology. 23(6)
Twenty-nine patients with progressive hormone-refractory metastatic adenocarcinoma of the prostate were treated with daily estramustine phosphate at 10 mg/kg, and I.V. doxorubicin 50 mg/m2 every 3 weeks. Twenty-six patients were evaluable. Four of se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64ab9f9b3e4833b68978735391435748
https://pubmed.ncbi.nlm.nih.gov/11202803
https://pubmed.ncbi.nlm.nih.gov/11202803
Autor:
R A, Decker, P, Elson, T F, Hogan, D L, Citrin, D W, Westring, T K, Banerjee, K W, Gilchrist, J, Horton
Publikováno v:
Surgery. 110(6)
From November 1979 to July 1986, 52 patients (27 women and 25 men; median age 52 years) with advanced adrenocortical carcinoma entered a prospective, nonrandomized study evaluating moderate-dose mitotane and doxorubicin hydrochloride (Adriamycin). Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f73ece42af321517bccf2753692c4dba
https://pubmed.ncbi.nlm.nih.gov/1745969
https://pubmed.ncbi.nlm.nih.gov/1745969
Publikováno v:
Journal of Clinical Oncology. 26:20706-20706
20706 Background: Multimodality therapy (MMTx) has replaced less complex forms of treatment for most BC pts. Unfortunately, improved tumor control may come at the cost of increased treatment-relate...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::942b4a94b276e143acca30a90d91d8b8
https://doi.org/10.1200/jco.2008.26.15_suppl.20706
https://doi.org/10.1200/jco.2008.26.15_suppl.20706
Autor:
D. L. Citrin
Publikováno v:
Radiology. 122:255-258
The in vitro properties of lyophilized 99mTc stannous diphosphonate bone-scanning agent have been studied with particular reference to those properties which are of relevance to its routine clinical use. The results of quantitative studies in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ddbbc748d7f401a082cbeb2e24a7ed
https://doi.org/10.1148/122.1.255
https://doi.org/10.1148/122.1.255
Publikováno v:
Clinical Nuclear Medicine. 2:364-367
Previous pharmacological studies have suggested that diphosphonates are superior bone scanning agents than pyrophosphate. The bone images obtained with both 99mTc-hydroxyethylidene diphosphonate and 99mTc-pyrophosphate were compared in a clinical stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::337a8828b722f6617dbe5b0a1907b1bb
https://doi.org/10.1097/00003072-197710000-00009
https://doi.org/10.1097/00003072-197710000-00009
Autor:
D. L. Citrin, Tom F. Hogan
Publikováno v:
Cancer. 50:201-206
Twenty-five patients with metastatic prostate cancer were treated with a combination of Adriamycin 50 mg/m2 and cis-platinum (CDDP) 50 mg/m2 every three weeks. Response was evaluated using radioisotope bone scan, serum acid phosphatase levels, and cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eea7f8ad017f30ef38120832e9881f67
https://doi.org/10.1002/1097-0142(19820715)50:2<201::aid-cncr2820500205>3.0.co
https://doi.org/10.1002/1097-0142(19820715)50:2<201::aid-cncr2820500205>3.0.co
Autor:
D. L. Citrin, William B. Ershler, A. I. Cohen, J. Harberg, S. Schlise, C. Hougen, T. E. Davis, Brian T. Pruitt, W. Zweibel
Publikováno v:
Cancer. 47:680-685
The accuracy levels of serial radioisotope bone scans and conventional bone radiographs in assessing the response of bone metastases to systemic therapy were compared in 34 women with metastatic breast cancer. Each patient had measurable or evaluable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62b1b0f0cefa4011d125e57d192ed5c0
https://doi.org/10.1002/1097-0142(19810215)47:4<680::aid-cncr2820470410>3.0.co
https://doi.org/10.1002/1097-0142(19810215)47:4<680::aid-cncr2820470410>3.0.co
Publikováno v:
British Journal of Surgery. 62:201-204
Comparison of the gamma camera bone scan and radiological survey in 190 patients with breast cancer has confirmed the superiority of the bone scan in the positive diagnosis of skeletal metastases. In 47 patients with known (X-ray positive) bony metas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10fe6414ac1be583e8b9ed2e3f0dc24e
https://doi.org/10.1002/bjs.1800620307
https://doi.org/10.1002/bjs.1800620307
Publikováno v:
The British Journal of Radiology. 53:874-877
99Tcm-HEDP bone scans were obtained in 20 acromegalic patients. Twelve patients had active disease with elevated basal serum human growth hormone (HGH) levels. Eight patients were in clinical and biochemical remission. The bone scans,assessed indepen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3e46ae1f29162a8d58e58ba8392f48
https://doi.org/10.1259/0007-1285-53-633-874
https://doi.org/10.1259/0007-1285-53-633-874